SQLite Web: event

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-024098.txt","as_of":"2026-04-08T02:28:02.401723+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-024098.txt","company":"Vir Biotechnology, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-024098.txt","article_chars":1897,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_99afd17139d541e4","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-024098.txt","content_type":"text/plain","enriched_at":"2026-04-08T03:32:03.323118+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-024098.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-024098.txt","source_event_id":"evt_e49b157f562c","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"e00df7c9672b46c9","kind":"sec_filing","published_at":"20260407","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-07","2026-04-06"],"entities":[{"asset_class":"equity","name":"Vir Biotechnology, Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Marianne De Backer","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Ureel-De Backer Family Trust","relevance":"medium","symbol":"","type":"trust"}],"event_type":"other","information_gaps":["The cleaned text does not clearly show whether the transaction is a sale or purchase beyond the footnote describing a sale; the exact Form 4 transaction table fields are not fully interpretable from the provided excerpt.","The excerpt does not provide the security ticker/symbol for Vir Biotechnology, Inc. (only issuer name and CIK are shown).","The excerpt does not provide the prior known state (what was previously known vs what changed), so the 'delta' relative to prior filings cannot be determined from the provided text alone."],"key_facts":["SEC accession number: 0001628280-26-024098.","Form type: 4 (Form 4).","Issuer: Vir Biotechnology, Inc. (CIK 0001706431).","Reporting owner: Marianne De Backer (CIK 0001797819).","Filing date (as of date): 2026-04-07; period of report: 2026-04-06.","The filing states the sale represents an automatic and mandatory sale under a Rule 10b5-1 arrangement to satisfy the issuer's tax withholding obligations in connection with the vesting of restricted stock units.","The shares are held in the name of the Ureel-De Backer Family Trust, of which the reporting person and her spouse are trustees.","The filing includes a price/transaction value line showing: 72559 shares and 9.156 (as presented in the cleaned text).","The filing includes a total value line showing: 948145 (as presented in the cleaned text)."],"numeric_claims":[{"label":"shares","value":"72559"},{"label":"price (as shown)","value":"9.156"},{"label":"total value (as shown)","value":"948145"},{"label":"transaction date (period of report)","value":"2026-04-06"}],"primary_claim":"On 2026-04-07, Vir Biotechnology, Inc. filed SEC Form 4 for reporting-owner Marianne De Backer showing an automatic Rule 10b5-1 sale of shares to satisfy tax withholding upon RSU vesting.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Vir Biotechnology, Inc. filed a Form 4 on 2026-04-07 reporting a transaction by Marianne De Backer (President and CEO). The filing indicates an automatic sale of shares under a Rule 10b5-1 arrangement to cover issuer tax withholding obligations tied to RSU vesting.","topics":["SEC Form 4","insider transaction","Rule 10b5-1","tax withholding","restricted stock units (RSUs)"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Vir Biotechnology, Inc. \u00b7 Filed 20260407","ticker":"VIR","tickers":["VIR"],"title":"VIR filed 4","url":"https://www.sec.gov/Archives/edgar/data/1706431/0001628280-26-024098.txt"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — signals

Update row sig_0b310606381c in signals